It’s easy to get lost in the acronyms, isn't it? The Centers for Medicare & Medicaid Services (CMS) has a knack for that, and their latest initiative, the Transforming Episode Accountability Model (TEAM), is no exception. Set to kick off in January 2026, TEAM is a mandatory, five-year program that’s poised to reshape how hospitals are reimbursed for certain high-cost procedures. While the official FY 2025 measures are still being finalized, the groundwork laid by recent CMS announcements and expert discussions offers a clear picture of what’s coming.
At its heart, TEAM is an episode-based payment model. This means hospitals will be measured and paid based on the total cost of care for a patient’s journey through specific procedures, rather than just the individual services rendered. Think of it as looking at the whole picture, from the initial surgery to recovery and any potential complications within a defined timeframe – typically 30 days.
The five episode categories targeted by TEAM are significant: lower extremity joint replacement (LEJR), surgical hip/femur fracture treatment (SHFFT), spinal fusion, coronary artery bypass graft (CABG), and major bowel procedures. These aren't niche services; they represent a substantial portion of Medicare inpatient volume nationwide, around 6%, according to industry analysts. This broad reach means many hospitals will be directly impacted.
So, how will hospitals be evaluated under TEAM? The model focuses on two main areas: fee-for-service (FFS) expenditures relative to a “target price” and care quality. This dual approach aims to incentivize both cost efficiency and high-quality patient outcomes. For LEJR episodes, specifically, the CMS total hip and knee arthroplasty patient-reported outcome – performance measure (THA/TKA PRO-PM) will be a key quality metric. This isn't entirely new territory, as orthopedic providers have been grappling with mandatory PRO-PM requirements since April 2024 as part of the hospital inpatient quality reporting program.
What’s striking about TEAM, as noted by experts, is the potential complexity and the challenge it presents, particularly for smaller, rural hospitals. The sheer volume of documentation, the intricate formulas, and the broad range of geographic areas included – from densely populated urban centers to remote critical access hospitals – raise questions about the feasibility of managing downside risk for facilities operating on thin margins, or even at a loss.
Managing this risk effectively requires a robust infrastructure. Hospitals will need to focus on three critical elements: accurate cost accounting, comprehensive collection of patient-reported outcome measures (PROMs), and skilled analytical capabilities. For many, this will mean investing in new staff, technology, or partnering with external experts. The experience with previous models, like the Comprehensive Care for Joint Replacement (CJR) model, demonstrated that these programs can drive down costs, but the scale and scope of TEAM present a new level of challenge.
While specific measure comparison tables for FY 2025 under TEAM are still emerging, the underlying principles are clear. Hospitals need to proactively understand their costs, embrace PROMs collection as a core function, and build the analytical muscle to interpret data and adapt their care pathways. The clock is ticking, and preparation now will be key to navigating this evolving landscape successfully.
